XTL Biopharmaceuticals Ltd

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
XTL Biopharmaceuticals Ltd
TickerXTLB
CIK #0001023549
CUSIP98386D307
SectorLife Sciences - Pharmaceutical Preparations
AddressXtl Biopharmaceuticals Ltd c/o Alston & Bird Llp, 90 Park Avenue, New York, NY 10016
Source [EDGAR]
CIK Filing 2011 - 2025
[0001023549] 6-K
[0001023549] D
[0001023549] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Intracoastal Capital LLC XTL Biopharmaceuticals Ltd [2017-02-27] 0.7
Sabby Management LLC XTL Biopharmaceuticals Ltd [2015-04-02] 4.87
Form 13F Holdings
Firm Period DFND Voting Shares
Noked Israel Ltd [2025-06-30] DFND 198,888 198,888
RhumbLine Advisers [2025-06-30] SOLE 17,261 17,261
Morgan Stanley [2025-06-30] DFND 11,011 11,011
UBS Group AG [2025-06-30] DFND 1,336 1,336
Concourse Financial Group Securities Inc [2025-06-30] SOLE 0 0
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com